Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Squalamine improves retinal neovascularization.

R D Higgins1, R J Sanders, Y Yan

  • 1Department of Pediatrics, Georgetown University Medical Center, Washington, DC 20007, USA. higginsr1@gunet.georgetown.edu

Investigative Ophthalmology & Visual Science
|May 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.

Oncogene·2026
Same author

Expanding bubbles in Orion A: [C <sub>II</sub>] observations of M42, M43, and NGC 1977.

Astronomy and astrophysics·2020
Same author

Research abstracts presented at the Eastern Allergy Conference, Palm Beach, Florida, May 6-9, 2010.

Allergy and asthma proceedings·2017
Same author

Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto Rico.

American journal of rhinology & allergy·2017
Same author

[Cii] emission from L1630 in the Orion B molecular cloud.

Astronomy and astrophysics·2017
Same author

Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same journal

Degeneration of Interpericyte Tunneling Nanotubes Can Occur in the Absence of Pericyte Loss in Diabetic Retina Disease.

Investigative ophthalmology & visual science·2026
Same journal

Unsupervised Clustering for POAG Phenotyping.

Investigative ophthalmology & visual science·2026
Same journal

Myd88 Deficiency Accelerates Retinal Degeneration and Alters Microglial Dynamics in a Mouse Model of Retinitis Pigmentosa.

Investigative ophthalmology & visual science·2026
Same journal

Sigma 1 Receptor Activation Coordinates Metabolic Stress Responses to Protect Retinal Vasculature in Ischemic Retinopathy.

Investigative ophthalmology & visual science·2026
Same journal

On the Misuse of Virus-Transformed Human Corneal Epithelial Cells as Surrogates for Normal Cells.

Investigative ophthalmology & visual science·2026
Same journal

Human Crystallin Variation and Cataract.

Investigative ophthalmology & visual science·2026
See all related articles

Squalamine, an antiangiogenic compound, significantly reduced retinopathy in a mouse model. This suggests squalamine may be a promising new treatment for ocular neovascularization.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Developmental Biology

Background:

  • Neovascularization is a key factor in retinopathy development.
  • Inhibiting neovascularization is a potential therapeutic strategy for retinopathy.
  • Squalamine is an amino sterol with known antiangiogenic properties.

Purpose of the Study:

  • To evaluate the efficacy of squalamine in a mouse model of oxygen-induced retinopathy (OIR).
  • To determine if squalamine can inhibit neovascularization associated with OIR.

Main Methods:

  • Oxygen-induced retinopathy (OIR) was established in C57BL6 mice.
  • Mice received daily squalamine doses or a single dose post-oxygen exposure.
  • Retinopathy was assessed using scoring systems and quantification of neovascular nuclei.

Related Experiment Videos

Main Results:

  • Squalamine treatment significantly reduced overall retinopathy scores compared to controls (P < 0.001).
  • Both five-day and single-dose squalamine regimens improved retinopathy.
  • A decrease in neovascular nuclei extending beyond the inner limiting membrane was observed with squalamine treatment (P < 0.01 and P < 0.001).

Conclusions:

  • Squalamine demonstrates significant therapeutic potential for retinopathy.
  • Squalamine may serve as a novel agent for treating ocular neovascularization.